1 Product identity
Ingredient risk
5 ingredients to use with caution

HumaPro

BrandALR IndustriesOther Combinations Tablet or Pill 28 ingredients 5 caution DSLD #30270
Net contents: 300 Coated Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2014-03-25
2 Ingredients (28)
IngredientGroupSafety
Particle-Sized Essential Amino Acid IR (Immediate Release) Proprietary Matrix:Proprietary Blend (Amino Acid/Protein)
L-LeucineLeucine
L-ValineValine
L-IsoleucineIsoleucine
L-LysineLysine
L-PhenylalaninePhenylalanine
L-ThreonineTHREONINE
L-MethionineMETHIONINE
L-TryptophanTryptophan
L-TyrosineTyrosine
Alpha-Glucan OligosaccharideAlpha Glucans
L-Leucine MalateLecine malate
Extended Time Release Proprietary Anti-Catabolic And Insulingenic Matrix:Proprietary Blend (Combination)
Bitter Melon Fractional ExtractBitter Melon
Coffee Bean ConcentrateCoffee
Vitamin & Mineral NNU Co-FactorsBlend (Combination)
Vitamin B1ThiaminUse with Caution
Vitamin B3NiacinConditionally Safe
Vitamin B6Vitamin B6Use with Caution
Vitamin B12Vitamin B12Use with Caution
Magnesium CitrateMagnesiumUse with Caution
Calcium CarbonateCalciumConditionally Safe
Zinc GluconateZincUse with Caution
Microcrystalline CelluloseCellulose
Carboxymethyl CelluloseCarboxy Methyl Cellulose
Sodium Starch GlycolateSodium Starch Glycolate
Magnesium StearateMagnesium stearateUse with Caution
SilicaSiliconGenerally Safe
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Thiamin — Wernicke encephalopathy: classic triad (confusion, ophthalmoplegia, ataxia) is present in only 16% of cases — any ONE element in an at-risk patie…
Vitamin B6 — Sensory neuropathy from chronic high-dose B6 (>200 mg/day) — presents as numbness, ataxia. Can be irreversible. Often self-prescribed by patients…
Vitamin B12 — Nitrous oxide anesthesia in subclinically B12-deficient patients can precipitate acute combined degeneration — always check B12 before elective p…
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
Zinc — Chronic zinc >40 mg/day without copper causes copper deficiency: anemia, neutropenia, myeloneuropathy [1].
3 Safety cross-reference
L-Leucine — Limited Evidence
⚠ May worsen pellagra
⚠ High doses may impair glucose metabolism
L-Lysine — Limited Evidence
⚠ GI discomfort at high doses
⚠ May increase calcium absorption
L-Phenylalanine — Limited Evidence
⚠ Dangerous in PKU
⚠ May raise blood pressure
L-Methionine — Limited Evidence
⚠ Raises homocysteine levels
⚠ May promote tumor growth
L-Tryptophan — Limited Evidence
⚠ Serotonin syndrome with SSRIs/MAOIs
⚠ Drowsiness
L-Tyrosine — Limited Evidence
⚠ May worsen hyperthyroidism
⚠ Migraine trigger in some
Thiamin — Use with Caution
Niacin — Conditionally Safe
⚠ Flushing at >50 mg
⚠ Hepatotoxicity at high doses
Vitamin B6 — Use with Caution
Vitamin B12 — Use with Caution
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Zinc — Use with Caution
⚠ Copper deficiency at >40 mg/day
⚠ Nausea, metallic taste
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID30270
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2014-03-25
6 More from ALR Industries
View ALR Industries Safety Scorecard → 3 products
HumaPro Exotic Peach Mango FlavorHyper Drive 3.0
7 Cite this page
Vancouver
Pkhakadze G. HumaPro — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 25]. Available from: https://supplement.ge/products/humapro-30270/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG